Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist series

Sangdon Han(Arena Pharmaceuticals (United States)), Robert M. Jones(Arena Pharmaceuticals (United States)), Woo Hyun Yoon(Arena Pharmaceuticals (United States)), Christopher J. Carroll(St George's, University of London), Graeme Semple(Eurofins (United States)), Sanju Narayanan(Arena Pharmaceuticals (United States)), Michael Morgan(Arena Pharmaceuticals (United States)), David J. Unett(Arena Pharmaceuticals (United States)), Hussein Al-Sharmma(Arena Pharmaceuticals (United States)), Dominic P. Behan, Daniel J. Buzard(Arena Pharmaceuticals (United States)), Imelda Calderon(Arena Pharmaceuticals (United States)), Hsin-Hui Shu(Arena Pharmaceuticals (United States)), Xiuwen Zhu(Arena Pharmaceuticals (United States)), Khawja A. Usmani(Arena Pharmaceuticals (United States)), Shiu-Feng Tung(Arena Pharmaceuticals (United States)), Chuan Chen(Shanghai East Hospital), Sun Hee Kim(Korea Basic Science Institute), Amy Wong(Arena Pharmaceuticals (United States)), Juerg Lehmann(Arena Pharmaceuticals (United States)), James Leonard(Arena Pharmaceuticals (United States)), Dawei Yue(Arena Pharmaceuticals (United States)), Zhi‐Liang Chu(Arena Pharmaceuticals (United States)), Abu Sadeque(Arena Pharmaceuticals (United States)), Andrew M. Kawasaki(Ionis Pharmaceuticals (United States))
Bioorganic & Medicinal Chemistry Letters
May 23, 2015
Cited by 13


Related Papers